Barely Significant
← all excerpts

Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer.

Clin Cancer Res · 2022 · PMC9377756 · PMID 34980602

Europe PMCDOI
1
hedged sentence
0.0550
closest p · 1.1× alpha
0.0550
boldest claim

The sentences

showed a trendP = 0.055so close (0.05 < p ≤ 0.1)
OS calculated from the beginning of immunotherapy showed a trend between patients with a CD3 + CD137 + PD1 + frequency < 1.85% and > 1.85% ( P = 0.055); however, this difference was not statistically significant ( Fig. 4E ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.